Attached files
| file | filename |
|---|---|
| EX-32.2 - CERTIFICATION - NEXUS BIOPHARMA INC | plata_ex322.htm |
| EX-31.1 - CERTIFICATION - NEXUS BIOPHARMA INC | plata_ex311.htm |
| EX-31.2 - CERTIFICATION - NEXUS BIOPHARMA INC | plata_ex312.htm |
| EXCEL - IDEA: XBRL DOCUMENT - NEXUS BIOPHARMA INC | Financial_Report.xls |
| 10-Q - FORM 10-Q - NEXUS BIOPHARMA INC | plata_10q.htm |
EXHIBIT 32.1
CERTIFICATE PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report (the “Report”) on the Form 10-Q of Plata Resources, Inc. (the “Company”) for the three months ended March 31, 2015, as filed with the Securities and Exchange Commission on the date hereof, I, Dexter R. Caliso, Chief Executive Officer, President and Director, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:
|
1. |
The Quarterly Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities and Exchange Act of 1934, as amended; and |
|
|
|
||
|
2. |
The information contained in this Quarterly Report fairly presents, in all material respects, the financial condition and results of operation of the Company. |
| Dated: May 5, 2015 | By: | /s/ Dexter R. Caliso | |
|
Dexter R. Caliso |
|||
| Chief Executive Officer, President and Director |